HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFF Pursues Sustainable Ingredients Development To Drive Fragrance Biz

This article was originally published in The Rose Sheet

Executive Summary

Partnering with Amyris, Inc. to develop sustainable fragrance ingredients is one strategy International Flavors & Fragrances is taking to boost the ingredients side of its business, which experienced an 11% sales decline in the first quarter.

You may also be interested in...



IFF Natural Ethics Ingredient Line Launches With Vanilla Offering

IFF launches its Natural Ethics line of ingredients to meet demand for high-quality natural flavor and fragrance ingredients, expecting its first vanilla offering to be available next year. In the firm’s Moving Forward report, the company announces other green initiatives launched in 2012, 2013.

Renewable Ingredient Firm Signs Givaudan, Boasts $10 Mil. "Pipeline Of Interest"

Renewable ingredients supplier Amyris is positioning itself as a go-to player in the sustainable cosmetics arena, projecting nearly $10 million in potential sales of cosmetic emollient squalane and announcing a new deal with Swiss fragrance house Givaudan.

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel